Literature DB >> 8388898

Human herpesvirus 6 inhibits the proliferative responses of human peripheral blood mononuclear cells.

R T Horvat1, M J Parmely, B Chandran.   

Abstract

Human herpesvirus 6 (HHV-6) was recently isolated from the blood of immunosuppressed individuals and children with exanthem subitum. In this study, the effect of HHV-6 on the proliferative response of human peripheral blood lymphocytes was tested. T cell lines or human peripheral blood lymphocytes were infected with HHV-6 variant A, strain GS, or variant B, strain Z29. Infected and uninfected cell lysates were UV inactivated and sonicated; when lysates were added to peripheral blood mononuclear cells from HHV-6-seropositive adults, lymphoproliferative responses to antigens (tuberculin purified protein derivative or mumps) and mitogens (phytohemagglutinin or interleukin-2) were inhibited in a dose-dependent manner. This inhibition was reversed by a rabbit anti-HHV-6(GS) antiserum, and inhibition was not due to cell lysis induced by viral infection, since cell death was not observed. This in vitro suppression of cellular immune responses by HHV-6 proteins may be relevant to the in vivo pathogenesis of HHV-6 and its relationship to human diseases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388898     DOI: 10.1093/infdis/167.6.1274

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  A study of childhood febrile convulsions with particular reference to HHV-6 infection: pathogenic considerations.

Authors:  M F Bertolani; M Portolani; F Marotti; A M Sabbattini; C Chiossi; M R Bandieri; G B Cavazzuti
Journal:  Childs Nerv Syst       Date:  1996-09       Impact factor: 1.475

3.  Inhibition of interleukin-2 gene expression by human herpesvirus 6B U54 tegument protein.

Authors:  Mathieu Iampietro; Guillaume Morissette; Annie Gravel; Louis Flamand
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

Review 4.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

5.  Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures.

Authors:  H Asada; V Klaus-Kovtun; H Golding; S I Katz; A Blauvelt
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

6.  Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S.

Authors:  M Lu; T Shenk
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

Review 7.  Immune response to HHV-6 and implications for immunotherapy.

Authors:  Aniuska Becerra; Laura Gibson; Lawrence J Stern; J Mauricio Calvo-Calle
Journal:  Curr Opin Virol       Date:  2014-10-27       Impact factor: 7.090

8.  Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection.

Authors:  Miki Kakimoto; Atsuhiko Hasegawa; Shigeru Fujita; Masaki Yasukawa
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Human herpesvirus type 6 indirectly enhances oligodendrocyte cell death.

Authors:  Hong Kong; Quinton Baerbig; Laine Duncan; Nick Shepel; Michael Mayne
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

10.  CD4 promoter transactivation by human herpesvirus 6.

Authors:  L Flamand; F Romerio; M S Reitz; R C Gallo
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.